Cosmo Pharmaceuticals N.V (C43) — Financial Flexibility Index
Cosmo Pharmaceuticals N.V (C43) has a Financial Flexibility Index of 0.02x as of June 2022. Free cash flow of €7.39 Million (operating CF €6.28 Million minus capex €1.11 Million) represents 0% of total liabilities (€296.03 Million). Also explore how fast is Cosmo Pharmaceuticals N.V growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cosmo Pharmaceuticals N.V Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Cosmo Pharmaceuticals N.V across 10 annual periods. Check strategic asset allocation of Cosmo Pharmaceuticals N.V to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Cosmo Pharmaceuticals N.V (2016–2025)
Year-by-year free cash flow to debt coverage for Cosmo Pharmaceuticals N.V. For the full company profile including market capitalisation, see market value of Cosmo Pharmaceuticals N.V.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.06x | €-7.02 Million | €-12.48 Million | €123.46 Million | ▼ -104.8% |
| 2024 | 1.19x | €168.06 Million | €162.41 Million | €141.68 Million | ▲ +196.8% |
| 2023 | 0.40x | €48.93 Million | €33.62 Million | €122.42 Million | ▲ +191.7% |
| 2022 | 0.14x | €40.54 Million | €33.23 Million | €295.80 Million | ▲ +121.8% |
| 2021 | 0.06x | €18.10 Million | €12.61 Million | €292.88 Million | ▼ -29.2% |
| 2020 | 0.09x | €17.11 Million | €12.98 Million | €196.04 Million | ▲ +200.6% |
| 2019 | -0.09x | €-16.60 Million | €-18.85 Million | €191.43 Million | ▼ -89.7% |
| 2018 | -0.05x | €-8.27 Million | €-10.16 Million | €180.83 Million | ▼ -144.5% |
| 2017 | 0.10x | €2.86 Million | €-9.43 Million | €27.86 Million | ▼ -92.9% |
| 2016 | 1.44x | €40.12 Million | €21.69 Million | €27.92 Million | — |